Have a personal or library account? Click to login
Staphylococcus aureus and Staphylococcus pseudintermedius isolated from humans and pets – a comparison of drug resistance and risk factors associated with colonisation Cover

Staphylococcus aureus and Staphylococcus pseudintermedius isolated from humans and pets – a comparison of drug resistance and risk factors associated with colonisation

Open Access
|Jun 2025

Figures & Tables

Prevalence in isolates from human, cat and dog swabs of methicillin-susceptible Staphylococcus pseudintermedious (MSSP) and methicillin-resistant S_ pseudintermedius (MRSP) strains, chi-squared test of independence and odds ratio (OR) for the determinants of MRSP

VariableMSSP (n (%)1)MRSP (n (%)1)OR95% ORP-value
Species
  Human1 (0.7)6 (21.4)
  Cat9 (6.6)8 (28.6)0.150.01–1.510.107
  Dog127 (92.7)14 (50.0)0.020.01–0.16<0.001
Clinical symptom
  Conjunctivitis20 (14.7)7 (35.0)3.121.11–9.780.025
  Inflammation of the ear canal23 (16.9)3 (15.0)0.870.23–3.200.830
  Rhinitis6 (4.4)5 (25.0)7.221.96–26.54<0.001
  Dermatitis/wounds37 (27.2)6 (30.0)1.150.41–3.210.794
  Other clinical symptoms15 (11.0)6 (30.0)3.461.15–10.350.020
Medical history
  Treatment given to a human284 (63.2)23 (92.0)6.711.52–29.680.005
  Antibiotics221 (28.0)15 (71.4)6.432.20–18.79<0.001
  Treatment given to the animal 359 (44.4)16 (80.0)5.021.59–15.810.003
Occupational risk
  Medical studies40 (0)1 (3.8)0.160.11–0.230.024
  Veterinary studies44 (3.0)4 (15.4)5.821.35–24.990.009
Origin of animals kept at home
  Commercial breeder13 (92.9)7 (53.8)0.090.01–0.900.021
  Adopted from the street4 (28.6)1 (7.7)0.210.02–2.180.163
  Adopted from another source51 (7.1)6 (46.2)11.141.11–112.010.021
Factor associated with the animal
  Cat with outdoor access6 (66.7)0 (0)0.040.01–0.970.010

Prevalence in isolates from human, cat and dog swabs of methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S_ aureus (MRSA) strains, chi-squared test of independence and odds ratio (OR) for the determinants of MRSA

VariableMSSA (n (%)1)MRSA (n (%)1)OR95% ORP-value
Species
  Human1 (0.7)6 (21.4)
  Cat9 (6.6)8 (28.6)1.450.56-3.730.443
  Dog127 (92.7)14 (50.0)1.160.36–3.750.806
Medical history
  Treatment given to a human265 (48.5)16 (50.0)1.060.49–2.300.879
  Antibiotics235 (27.6)12 (41.4)1.850.80–4.280.143
Factors associated with the animal
  Antibiotics340 (42.6)5 (17.2)0.280.10–0.800.013
  Cat with outdoor access6 (75.0)2 (50.0)0.330.03–4.190.547

Frequency of Staphylococcus aureus and S_ pseudintermedius strains by swabbed locationand host species

LocationHuman (n1 = 155)Cat (n1 = 28)Dog (n1 = 19)
S. aureusoral cavity47 (30.3%)10 (35.7%)4 (21.1%)
nasal vestibule68 (43.8%)10 (35.7%)7 (36.8%)
conjunctival sacnot applicable4 (14.3%)2 (10.5%)
ear224 (15.5%)1 (3.6%)1 (5.3%)
skin in the elbow flexure16 (10.3%)not applicablenot applicable
skin in the groinnot applicable2 (7.1%)2 (10.5%)
anusnot applicable01 (5.3%)
woundnot applicable1 (3.6%)2 (10.5%)
LocationHuman (n1 = 7)Cat (n1 = 17)Dog (n1 = 141)
S. pseudintermediusoral cavity03 (17.6%)29 (20.6%)
nasal vestibule3 (42.9%)5 (29.4%)26 (18.4%)
conjunctival sacnot applicable4 (23.5%)23 (16.3%)
ear21 (14.2%)2 (11.8%)17 (12.1%)
skin in the elbow flexure3 (42.9%)not applicablenot applicable
skin in the groinnot applicable2 (11.8%)17 (12.1%)
anusnot applicable1 (5.9%)26 (18.4%)
woundnot applicable03 (2.1%)

The incidence in isolates from human, cat and dog swabs of Staphylococcus aureus and S_ pseudintermedius strains resistant to selected antimicrobial chemotherapeutics

SubstanceS. aureus (n1 = 202)S. pseudintermedius (n1 = 165)
ResistanceResistance
AMP126 (62.4%)105 (63.6%)
AMC57 (28.2%)13 (7.9%)
PG124 (61.4%)118 (71.5%)
FD4 (2.0%)1 (0.6%)
MUP7 (3.5%)0 (0%)
GM1 (0.5%)22 (13.3%)
CIP10 (5.0%)18 (10.9%)
OX/FOX*9 (4.5%)20 (12.1%)
LZD2 (1.0%)0 (0%)
MAR10 (5.0%)18 (10.9%)
DA11 (5.4%)68 (41.2%)
C4 (2.0%)39 (23.6%)
RD3 (1.5%)0 (0%)
TOB1 (0.5%)9 (5.5%)
E59 (29.2%)68 (41.2%)

Frequency distribution of multidrug-resistant (MDR) Staphylococcus aureus strains at the genotypic and phenotypic level by host species

Analysis levelSpeciesNot MDRMDRP-value2
Genotypic (n1 = 192)human101 (68.2%)47 (31.8%)0.553
cat17 (65.4%)9 (34.6%)
dog10 (55.6%)8 (44.4%)
Phenotypic (n1 = 202)human144 (92.9%)11 (7.1%)0.788
cat25 (96.2%)1 (3.8%)
dog19 (90.5%)2 (9.5%)

Frequency distribution of multidrug-resistant (MDR) Staphylococcus pseudintermedius strains at the genotypic and phenotypic level by host species

Analysis levelSpeciesNot MDRMDRP-value1
Genotypic (n = 165)human4 (57.1%)3 (42.9%)0.025
cat3 (17.6%)14 (82.4%)
dog73 (51.8%)68 (48.2%)
Phenotypic (n = 165)human4 (57.2%)3 (42.8%)0.939
cat9 (52. 9%)8 (47.1%)
dog83 (58.9%)58 (41.1%)

Frequency of occurrence of Staphylococcus aureus and S_ pseudintermedius strains carrying a given resistance gene in isolates from human, cat and dog swabs

GeneCarriage rate
S. aureus (n1 = 192)S. pseudintermedius (n1 = 165)
mecA217 (8.7%)24 (14.5%)
mecC28 (4.1%)5 (3.0%)
blaZ153 (79.7%)139 (84.2%)
tet[L]0 (0%)8 (4.8%)
tet[K]14 (7.3%)44 (26.7%)
tet[O]11 (5.7%)1 (0.6%)
tet[M]102 (53.1%)88 (53.3%)
ermA57 (29.7%)17 (10.3%)
ermB44 (22.9%)63 (38.2%)
ermC9 (4.7%)10 (6.1%)
aac (6′)-Ie-aph(2″)-Ia9 (4.7%)31 (18.8%)
mupA0 (0%)0 (0%)
vanA24 (12.5%)21 (12.7%)
vanB6 (3.1%)5 (3.0%)
fusB26 (3.1%)1 (0.6%)
Language: English
Page range: 199 - 211
Submitted on: Jan 1, 2025
Accepted on: Jun 10, 2025
Published on: Jun 18, 2025
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Marta Miszczak, Agnieszka Korzeniowska-Kowal, Anna Wzorek, Paulina Prorok, Leszek Szenborn, Krzysztof Rypuła, Karolina Bierowiec, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution 4.0 License.